Skip to content
10-Q

Quarterly Report

Arno Therapeutics, Inc

0001144204-16-102532

← back to feed
Filed
May 16, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 11, 2016 41.56M sh
Long Term Debt Q1 2016 · Mar 31, 2016 $0
Long Term Debt Q1 2016 · Dec 31, 2015 $2.09M
Cash And Equivalents Q1 2016 · Mar 31, 2016 $2.68M
Cash And Equivalents Q1 2016 · Dec 31, 2015 $66.99K
Cash And Equivalents Q1 2016 · Mar 31, 2015 $4.93M
Cash And Equivalents Q1 2016 · Dec 31, 2014 $7.95M
Stockholders Equity Q1 2016 · Mar 31, 2016 −$4.02M
Stockholders Equity Q1 2016 · Dec 31, 2015 −$8.62M
Current Liabilities Q1 2016 · Mar 31, 2016 $1.3M
Current Liabilities Q1 2016 · Dec 31, 2015 $4.23M
Total Liabilities Q1 2016 · Mar 31, 2016 $6.95M
Total Liabilities Q1 2016 · Dec 31, 2015 $8.99M
Current Assets Q1 2016 · Mar 31, 2016 $2.89M
Current Assets Q1 2016 · Dec 31, 2015 $327.68K
Total Assets Q1 2016 · Mar 31, 2016 $2.92M
Total Assets Q1 2016 · Dec 31, 2015 $361.24K
Sga Expense Q1 2016 · Mar 31, 2016 $1.28M
Sga Expense Q1 2016 · Mar 31, 2015 $1.39M
Rd Expense Q1 2016 · Mar 31, 2016 $1.54M
Rd Expense Q1 2016 · Mar 31, 2015 $2.47M
Net Income Q1 2016 · Mar 31, 2016 −$3.71M
Net Income Q1 2016 · Mar 31, 2015 −$3.39M
Operating Income Q1 2016 · Mar 31, 2016 −$2.83M
Operating Income Q1 2016 · Mar 31, 2015 −$3.86M